Medical imaging dose optimisation from ground up: expert opinion of an international summit.


Journal Article

As in any medical intervention, there is either a known or an anticipated benefit to the patient from undergoing a medical imaging procedure. This benefit is generally significant, as demonstrated by the manner in which medical imaging has transformed clinical medicine. At the same time, when it comes to imaging that deploys ionising radiation, there is a potential associated risk from radiation. Radiation risk has been recognised as a key liability in the practice of medical imaging, creating a motivation for radiation dose optimisation. The level of radiation dose and risk in imaging varies but is generally low. Thus, from the epidemiological perspective, this makes the estimation of the precise level of associated risk highly uncertain. However, in spite of the low magnitude and high uncertainty of this risk, its possibility cannot easily be refuted. Therefore, given the moral obligation of healthcare providers, 'first, do no harm,' there is an ethical obligation to mitigate this risk. Precisely how to achieve this goal scientifically and practically within a coherent system has been an open question. To address this need, in 2016, the International Atomic Energy Agency (IAEA) organised a summit to clarify the role of Diagnostic Reference Levels to optimise imaging dose, summarised into an initial report (Järvinen et al 2017 Journal of Medical Imaging 4 031214). Through a consensus building exercise, the summit further concluded that the imaging optimisation goal goes beyond dose alone, and should include image quality as a means to include both the benefit and the safety of the exam. The present, second report details the deliberation of the summit on imaging optimisation.

Full Text

Duke Authors

Cited Authors

  • Samei, E; Järvinen, H; Kortesniemi, M; Simantirakis, G; Goh, C; Wallace, A; Vano, E; Bejan, A; Rehani, M; Vassileva, J

Published Date

  • September 2018

Published In

Volume / Issue

  • 38 / 3

Start / End Page

  • 967 - 989

PubMed ID

  • 29769433

Pubmed Central ID

  • 29769433

Electronic International Standard Serial Number (EISSN)

  • 1361-6498

Digital Object Identifier (DOI)

  • 10.1088/1361-6498/aac575


  • eng

Conference Location

  • England